Որոնման արդյունքները - Deepak Kumar Deep
- Ցուցադրվում են 1 - 4 արդյունքները 4
-
1
Correction: Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India V. Ramesh, Ruchi Singh, Kumar Avishek, Aditya Verma, Deepak Kumar Deep, Sandeep Verma, Poonam Salotra
Հրապարակվել է 2015Errata/Corrigenda -
2
-
3
Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress Deepak Kumar Deep, Ruchi Singh, Vasundhra Bhandari, Aditya Verma, Vanila Sharma, Saima Wajid, Shyam Sundar, V. Ramesh, Jean‐Claude Dujardin, Poonam Salotra
Հրապարակվել է 2017Artigo -
4
Drug Susceptibility in Leishmania Isolates Following Miltefosine Treatment in Cases of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis Vasundhra Bhandari, Arpita Kulshrestha, Deepak Kumar Deep, Olivia Stark, Vijay Kumar Prajapati, V. Ramesh, Shyam Sundar, Gabriele Schönian, Jean‐Claude Dujardin, Poonam Salotra
Հրապարակվել է 2012Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Leishmaniasis
Miltefosine
Visceral leishmaniasis
Amastigote
Computer science
Immunology
Leishmania
Leishmania donovani
Medicine
Parasite hosting
World Wide Web
Antibiotics
Biology
Drug resistance
Microbiology
Aminoglycoside
Biochemistry
Ciprofloxacin
Dermatology
Gastroenterology
Infectivity
Internal medicine
Intracellular
Ofloxacin
Paromomycin
Pathology
Regimen
Surgery
Traditional medicine
Virus